316 related articles for article (PubMed ID: 26978333)
1. Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics.
Noh K; Kang Y; Nepal MR; Jeong KS; Oh DG; Kang MJ; Lee S; Kang W; Jeong HG; Jeong TC
Molecules; 2016 Mar; 21(3):337. PubMed ID: 26978333
[TBL] [Abstract][Full Text] [Related]
2. Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin.
Kang MJ; Ko GS; Oh DG; Kim JS; Noh K; Kang W; Yoon WK; Kim HC; Jeong HG; Jeong TC
Arch Pharm Res; 2014 Mar; 37(3):371-8. PubMed ID: 23771520
[TBL] [Abstract][Full Text] [Related]
3. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
[TBL] [Abstract][Full Text] [Related]
4. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form.
Akao T; Kawabata K; Yanagisawa E; Ishihara K; Mizuhara Y; Wakui Y; Sakashita Y; Kobashi K
J Pharm Pharmacol; 2000 Dec; 52(12):1563-8. PubMed ID: 11197087
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats.
Lu T; Song J; Huang F; Deng Y; Xie L; Wang G; Liu X
J Ethnopharmacol; 2007 Apr; 110(3):412-8. PubMed ID: 17110066
[TBL] [Abstract][Full Text] [Related]
6. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract.
Xing J; Chen X; Sun Y; Luan Y; Zhong D
J Pharm Pharmacol; 2005 Jun; 57(6):743-50. PubMed ID: 15969929
[TBL] [Abstract][Full Text] [Related]
7. Influence of coptis Chinensis on pharmacokinetics of flavonoids after oral administration of radix Scutellariae in rats.
Shi R; Zhou H; Liu Z; Ma Y; Wang T; Liu Y; Wang C
Biopharm Drug Dispos; 2009 Oct; 30(7):398-410. PubMed ID: 19688740
[TBL] [Abstract][Full Text] [Related]
8. Effects of Intestinal Microecology on Metabolism and Pharmacokinetics of Oral Wogonoside and Baicalin.
Xing S; Wang M; Peng Y; Li X
Nat Prod Commun; 2017 Apr; 12(4):509-514. PubMed ID: 30520584
[TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.
Lai MY; Hsiu SL; Tsai SY; Hou YC; Chao PD
J Pharm Pharmacol; 2003 Feb; 55(2):205-9. PubMed ID: 12631413
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin.
Wang CZ; Zhang CF; Chen L; Anderson S; Lu F; Yuan CS
Int J Oncol; 2015 Nov; 47(5):1749-58. PubMed ID: 26398706
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the absorption kinetics of baicalin and baicalein in rats' stomachs and intestines].
Liu TM; Jiang XH
Zhongguo Zhong Yao Za Zhi; 2006 Jun; 31(12):999-1001. PubMed ID: 17048649
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review.
Cui L; Yuan T; Zeng Z; Liu D; Liu C; Guo J; Chen Y
Biomed Pharmacother; 2022 Jul; 151():113191. PubMed ID: 35643068
[TBL] [Abstract][Full Text] [Related]
13. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
[TBL] [Abstract][Full Text] [Related]
14. [Effect of PEG400 on pharmacokinetics of baicalin and baicalein in gut microbiotadysbiosis rats].
Gu T; Zhang S; Zhang M; Meng XX; Gao XL
Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(5):1034-1040. PubMed ID: 30989866
[TBL] [Abstract][Full Text] [Related]
15. Oral pharmacokinetics of baicalin, wogonoside, oroxylin A 7-O-β-d-glucuronide and their aglycones from an aqueous extract of Scutellariae Radix in the rat.
Cai Y; Li S; Li T; Zhou R; Wai AT; Yan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():124-133. PubMed ID: 26809374
[TBL] [Abstract][Full Text] [Related]
16. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors.
Gong WY; Zhao ZX; Liu BJ; Lu LW; Dong JC
Eur J Med Chem; 2017 Jan; 126():844-852. PubMed ID: 27960146
[TBL] [Abstract][Full Text] [Related]
17. Flavone-catalyzed apoptosis in Scutellaria baicalensis.
Hirunuma M; Shoyama Y; Sasaki K; Sakamoto S; Taura F; Shoyama Y; Tanaka H; Morimoto S
Phytochemistry; 2011 Jun; 72(8):752-60. PubMed ID: 21377703
[TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects.
Li M; Shi A; Pang H; Xue W; Li Y; Cao G; Yan B; Dong F; Li K; Xiao W; He G; Du G; Hu X
J Ethnopharmacol; 2014 Oct; 156():210-5. PubMed ID: 25219601
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of baicalein after oral administration in monkeys.
Tian S; He G; Song J; Wang S; Xin W; Zhang D; Du G
Fitoterapia; 2012 Apr; 83(3):532-40. PubMed ID: 22245084
[TBL] [Abstract][Full Text] [Related]
20. Protective role of intestinal bacterial metabolism against baicalin-induced toxicity in HepG2 cell cultures.
Khanal T; Kim HG; Choi JH; Park BH; Do MT; Kang MJ; Yeo HK; Kim DH; Kang W; Jeong TC; Jeong HG
J Toxicol Sci; 2012; 37(2):363-71. PubMed ID: 22467027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
